Sereno TS, Cote EL

Language: Spanish
References: 13
Page: 90-95
PDF size: 122.26 Kb.

ABSTRACT

Objective: To know the clinical and research experience on metabolic surgery in Mexico.
Setting: XXXIII International Congress of General Surgery of the Mexican Association of General Surgery (AMCG, for its initials in Spanish).
Design: Surveys.
Statistical analysis: Percentages as summary measures for qualitative variables.
Material and methods: According to the database of the AMCG, surgeons with experience in bariatric surgery and who had participated in metabolic surgery (for type 2 diabetes mellitus) in Mexico were invited, as well as endocrinologists, researches and representatives of the Health Ministry and of Public Health Institute Workshops were organized in which questionnaires and topics related to metabolic surgery were answered and discussed.
Results: Of the participants, 81% considers that the gastric bypass achieves the best results for the control of type 2 diabetes (DM2) in obese patients with DM2, 59% consider that both the proximal and distal intestine participate in this process, that this procedure should be performed in all DM2 patients with a body mass index (BMI) › 35, but when the patient with DM2 has a BMI ‹ 35, he/she should only be subjected to surgery in specialized centers and under research protocols. The clinical surgical teams have the support of a nutriologist, psychologist in 100% of them; 78% have also the support by an endocrinologist; 56% count upon a support group; and only 18% have sports medicine. Regarding research on surgery for diabetes, the specialists responded that 36% have participated in clinical research and 24% in basic research. All (100%) consider it important or a priority to continue the research on the beneficial effect of the bypass on DM2, and that a database must be developed on the subject.
Conclusion: Gastric bypass is the surgery most often performed by the participants in the Forum in patients with DM2 and BMI › 35. In patients with DM2 and BMI ‹ 35, this procedure should only be performed under research protocols by multidisciplinary teams. A greater participation of the surgeon in the research of metabolic surgery is required.

REFERENCES

1. Secretaría de Salud. Dirección General de Información a la Salud. CONAPO, 2002. Proyecciones de la Población de México, 2000-2050.

2. Zimmet P. The burden of type 2 diabetes: Are we doing enough? Diabetes Metab 2003; 29: 6S9-18.

3. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.

4. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-352.

5. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-485.

6. Torquati A, Lutfi R, Abumrad N, Richards WO. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointestinal Surg 2005; 9: 1112-1118.

7. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477-484.

8. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323.

9. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SF, et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.

10. Dixon JB. Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes. World J Surg 2009; 33: 2014-21.

11. Rubino F, Kaplan LM, Schauer PR, Cummings DE; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399-405.

12. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11.

13. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749.